145 related articles for article (PubMed ID: 28796679)
1. Delivery After 40 Weeks of Gestation in Pregnant Women With Well-Controlled Human Immunodeficiency Virus.
Scott RK; Chakhtoura N; Burke MM; Cohen RA; Kreitchmann R
Obstet Gynecol; 2017 Sep; 130(3):502-510. PubMed ID: 28796679
[TBL] [Abstract][Full Text] [Related]
2. Missed Opportunities for Prevention of Mother-to-Child Transmission of Human Immunodeficiency Virus.
Scott GB; Brogly SB; Muenz D; Stek AM; Read JS;
Obstet Gynecol; 2017 Apr; 129(4):621-628. PubMed ID: 28277349
[TBL] [Abstract][Full Text] [Related]
3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
5. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
6. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
[TBL] [Abstract][Full Text] [Related]
7. Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.
Venkatesh KK; Morrison L; Livingston EG; Stek A; Read JS; Shapiro DE; Tuomala RE
Obstet Gynecol; 2018 May; 131(5):879-890. PubMed ID: 29630021
[TBL] [Abstract][Full Text] [Related]
8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
9. Mother-to-child transmission of human immunodeficiency virus in aten years period.
Delicio AM; Milanez H; Amaral E; Morais SS; Lajos GJ; e Silva JL; Cecatti JG
Reprod Health; 2011 Nov; 8():35. PubMed ID: 22129112
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
Avram CM; Greiner KS; Tilden E; Caughey AB
Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
[TBL] [Abstract][Full Text] [Related]
11. Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial.
João EC; Morrison RL; Shapiro DE; Chakhtoura N; Gouvèa MIS; de Lourdes B Teixeira M; Fuller TL; Mmbaga BT; Ngocho JS; Njau BN; Violari A; Mathiba R; Essack Z; Pilotto JHS; Moreira LF; Rolon MJ; Cahn P; Prommas S; Cressey TR; Chokephaibulkit K; Werarak P; Laimon L; Hennessy R; Frenkel LM; Anthony P; Best BM; Siberry GK; Mirochnick M
Lancet HIV; 2020 May; 7(5):e322-e331. PubMed ID: 32386720
[TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
13. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
14. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
[TBL] [Abstract][Full Text] [Related]
15. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
[TBL] [Abstract][Full Text] [Related]
16. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
[TBL] [Abstract][Full Text] [Related]
17. Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.
Thompson DR; Momplaisir FM; Adams JW; Yehia BR; Anderson EA; Alleyne G; Brady KA
PLoS One; 2015; 10(12):e0144592. PubMed ID: 26657902
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy Profile and Infant Outcomes Among HIV Infected Women Who Delivered in Cipto Mangunkusumo Hospital.
Indarti J; Yunihastuti E; Kurniati N; Aprilia B; Pamungkas DT; Chiprion AT; Ginting MA; Rizal S; Dewi C; Handayani L
Acta Med Indones; 2020 Jan; 52(1):55-62. PubMed ID: 32291372
[TBL] [Abstract][Full Text] [Related]
19. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
Kowalska A; Niemiec T; El Midaoui A; Burkacka E
Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
[TBL] [Abstract][Full Text] [Related]
20. [The reduction of mother-child transmission of HIV infection in developing countries: potential intervention strategies, obstacles to implementation and perspectives. The Reduction of Mother-Child Transmission of HIV Infection in Africa Group].
Meda N; Msellati P; Welffens-Ekra C; Cartoux M; Leroy V; Van de Perre P; Salamon R
Sante; 1997; 7(2):115-25. PubMed ID: 9273118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
